HYPERFIBRINOLYSIS

This adverse event was reported 55 times

HYPERFIBRINOLYSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AMINOCAPROIC ACID 1 0.0012
1 DACTINOMYCIN 2 0.0009
2 CHLORAMBUCIL 2 0.0005
3 ETOMIDATE INJECTION 1 0.0005
4 SUCCINYLCHOLINE CHLORIDE 1 0.0004
5 ETOMIDATE 1 0.0004
6 RASBURICASE 1 0.0004
7 ARTIFICIAL TEARS 1 0.0004
8 POLYVINYL ALCOHOL, POVIDONE 1 0.0004
9 FILGRASTIM-SNDZ 1 0.0003
See all drugs enriched for association with HYPERFIBRINOLYSIS

HYPERFIBRINOLYSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 2 0.0009
1 Plasma Volume Expander [EPC] 1 0.0003
2 Vitamin K [EPC] 2 0.0002
3 Antifibrinolytic Agent [EPC] 2 0.0002
4 Fluoroquinolone Antibacterial [EPC] 13 0.0001
5 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
6 Anticholinergic [EPC] 1 0.0001
7 General Anesthetic [EPC] 2 0.0000
8 Bile Acid [EPC] 1 0.0000
9 Nucleoside Metabolic Inhibitor [EPC] 9 0.0000
See all drug classes enriched for association with HYPERFIBRINOLYSIS